Table 7 Frequency of HCV recurrence among CRS categories; donor steatosis groups. CRS subgroups are high risk, CRS > 0.7; moderate risk, CRS 0.5–0.7; low risk, CRS < 0.5
From: Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation
| Â | Liver transplanted patients | P value | ||||
|---|---|---|---|---|---|---|
HCV recurrence | Non-recurrence | |||||
Count | % | Count | % | |||
CRS SCORE | Low risk | 10 | 33.3% | 15 | 34.1% | 0.943 |
Moderate risk | 12 | 40.0% | 16 | 36.4% | ||
High risk | 8 | 26.7% | 13 | 29.5% | ||
Donor steatosis % | Low<3.5 | 12 | 38.7% | 39 | 81.3% | <0.001 |
High>3.5 | 19 | 61.3% | 9 | 18.8% | ||